On February 28, 2025, Frost & Sullivan (referred to as 'Frost & Sullivan') and the Beijing Pain Challenge Public Welfare Foundation (referred to as 'Pain Challenge Foundation') jointly released the '2025 China Rare Disease Industry Trend Observation Report' (hereinafter referred to as the 'Report').
The Report is the fourth annual trend observation report jointly released by Frost & Sullivan and the Foundation for Rare Diseases. The Report aims to review and sort out the new progress made in China's rare disease field in 2024 in terms of policy support, diagnosis and treatment, special medical foods, drug research and development, investment and mergers and acquisitions, development prospects, etc. It provides a comprehensive overview of the progress made in this field in 2024 and the industry challenges it faces, as well as prospects for China's comprehensive rare disease service system. It offers a panoramic industry overview for all sectors of society, hoping to benefit policymakers, advocates, practitioners of relevant institutions, patients and their families in the rare disease field.
